NCT00892840View on ClinicalTrials.gov

Multiple-Ascending Dose Study

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Depression
Interventions
DRUG

BMS-820836

Oral Solution, Oral, 0.1 mg to 4 mg, Once daily, 14 days

DRUG

Placebo

Oral Solution, Oral, 0 mg, Once daily, 14 days

Trial Locations (1)

751 23

Local Institution, Uppsala

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY